7ZGW image
Deposition Date 2022-04-04
Release Date 2022-10-26
Last Version Date 2024-02-07
Entry Detail
PDB ID:
7ZGW
Title:
Serratia NucC apo form
Biological Source:
Source Organism:
Serratia (Taxon ID: 613)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.83 Å
R-Value Free:
0.20
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Serratia NucC
Gene (Uniprot):CWC46_19930, Ser39006_019925
Chain IDs:A, B, C (auth: D), D (auth: C), E, F
Chain Length:256
Number of Molecules:6
Biological Source:Serratia
Primary Citation
Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection.
Mol.Cell 82 4471 4486.e9 (2022)
PMID: 36395770 DOI: 10.1016/j.molcel.2022.10.028

Abstact

Bacteria have diverse defenses against phages. In response, jumbo phages evade multiple DNA-targeting defenses by protecting their DNA inside a nucleus-like structure. We previously demonstrated that RNA-targeting type III CRISPR-Cas systems provide jumbo phage immunity by recognizing viral mRNA exported from the nucleus for translation. Here, we demonstrate that recognition of phage mRNA by the type III system activates a cyclic triadenylate-dependent accessory nuclease, NucC. Although unable to access phage DNA in the nucleus, NucC degrades the bacterial chromosome, triggers cell death, and disrupts phage replication and maturation. Hence, type-III-mediated jumbo phage immunity occurs via abortive infection, with suppression of the viral epidemic protecting the population. We further show that type III systems targeting jumbo phages have diverse accessory nucleases, including RNases that provide immunity. Our study demonstrates how type III CRISPR-Cas systems overcome the inaccessibility of jumbo phage DNA to provide robust immunity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures